Current Partners/Sponsors

	CSUCI Alzheimer’s Institute Our tools help in the identification of novel drug leads for Alzheimer's disease.
	Collaborative Drug Discovery Our suite of tools helps in the analysis of neglected disease data.
	Cognition Therapeutics Inc. Our tools contribute to the design of small molecule antagonists of toxic soluble amyloid oligomer for Alzheimer's disease.
	University of California, Santa Barbara We collaborate closely with UC researchers on the development of novel graph querying and mining methods.

 

New Collaborators

Acelot is seeking collaborators on the following tasks:

• In silico prediction of biological activity: Acelot’s tools can be used to screen a database of compounds for biological activity. The result set can be ranked based on expected activity.
• Synthesis of pharmacophore models: Acelot’s tools can be used to synthesize pharmacophore models based on the results of a screen.
• Development of drug discovery tools: The advantages of graph based querying and mining open up the possibility of a number of specific tools in the drug discovery pipeline.  Acelot  is looking to partner and develop these specific solutions.

If you are seeking to reduce costs through better models and predictions or looking for cheaper ways to find lead compounds, please contact us.